Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beraprost Sodium in STEMI After Reperfusion
NCT05103813Phase 1Unknown
- Sponsor
- Shenzhen People's Hospital
- Start
- May 2022
- Primary completion
- Dec 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1 trial of beraprost in myocardial infarction (MI), sponsored by Shenzhen People's Hospital. Primary endpoint: Major Adverse Cardiovascular Events at 1 year. Status: unknown.
02
Drugs
beraprost
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT05103813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05103813.